| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16130065 |
| PharmacoGx | BRD-K16130065 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGFR1OP2 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0009 |
| mRNA | CRELD2 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.001 |
| mRNA | C2CD3 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.001 |
| mRNA | BEST4 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | LILRB1 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | SDS | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | APOBEC3G | CTRPv2 | pan-cancer | AAC | 0.25 | 0.001 |
| mRNA | PTK2B | CTRPv2 | pan-cancer | AAC | 0.29 | 0.001 |
| mRNA | UGDH | CTRPv2 | pan-cancer | AAC | 0.26 | 0.001 |
| mRNA | NFASC | CTRPv2 | pan-cancer | AAC | 0.26 | 0.001 |
